Price movement over the last 24 hours
Align Technology, Inc. vs Alexandria Real Estate Equities Inc — how do they compare? Align Technology, Inc. trades at $175.7 (market cap $13.27B), while Alexandria Real Estate Equities Inc trades at $48.34 (market cap $8.61B). The key difference: Align Technology, Inc. is the larger of the two by market cap, and Alexandria Real Estate Equities Inc pays a 5.83% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | ARE | |
|---|---|---|
Market Cap | $13.27B | $8.61B |
Sector | Health | Real Estate |
52-Week High | $207.19 | $87.45 |
52-Week Low | $124.88 | $40.41 |
Enterprise Value | $12.32B | $21.07B |
Dividend Yield | — | 5.83% |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $185.22, up 0.38% today, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results expected soon. Revenue remains stable around $4.0B, supported by a 67.57% gross margin and positive cash flow trends. Recent news highlights global expansion and product innovation, including a new manufacturing facility in India.
Outlook is positive with a $220.75 consensus price target, though risks include regulatory scrutiny from the European Commission and competitive pressures. The stock's valuation at a P/E of 31.65 reflects growth expectations, but investors should monitor execution on international growth and demand stability in North America.
Alexandria Real Estate Equities (ARE) trades at $49.41, down 6.03% over 24 hours amid bearish technical signals and mixed fundamentals. The stock shows negative profitability with -37.09% net income margin and -6.43% ROE, though valuation metrics like P/B of 0.55 suggest potential undervaluation. Recent earnings have been inconsistent with two misses in the last four quarters. The company maintains strong operational cash flow of $1.41B and declared a $0.72 dividend for Q2 2026.
ARE faces headwinds from declining occupancy guidance and net losses, but analyst consensus remains cautiously optimistic with a $51 price target and 37.5% buy ratings. Key risks include high debt levels (40.79% debt-to-asset ratio) and uneven demand in life science real estate. The stock's current position near support at $49 offers potential for recovery if operational improvements materialize.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.
Read more on ARE →